How seasonal affective disorder eating works on GLP-1 medication differs from standard nutritional guidance because your gastric emptying is 30-50% slower, your appetite is pharmacologically reduced, and your total caloric intake has dropped significantly.
Beyond improving glycemic control and promoting weight loss, GLP-1 RAs exert central actions relevant to mood disorders, including modulation of dopaminergic reward pathways, enhancement of hippocampal neurogenesis, attenuation of neuroinflammation, and regulation of appetite and energy balance.
This systematic review examines the current literature on glucagon-like peptide-1 receptor agonists (GLP-1RAs)-associated psychiatric manifestations, including depression, suicidality, eating disorders, substance use disorders (SUD) and schizophrenia spectrum disorders.
Furthermore, visual representations like the one above help us fully grasp the concept of Managing Blood Sugar And Seasonal Affective Disorder On A Glp-1 Diet.
Improved Blood Sugar Control: By increasing insulin secretion and reducing glucagon release when needed, GLP-1 drugs help maintain stable blood sugar levels which is especially helpful for people with type 2 diabetes.
